AHA Comments on Medicare Advantage Proposed Rule for Contract Years 2021 and 2022

The American Hospital Association appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ proposed regulation regarding policy and technical changes to Medicare Advantage and Part D prescription drug program for Contract Years 2021 and 2022. The proposed rule addresses a number of areas of importance to hospitals and health systems, including those that sponsor MA plans.

The AHA supports CMS’s efforts to provide plans with additional flexibilities to facilitate innovation under the MA program to meet the unique and complex needs of the Medicare population. We, however, have concerns regarding several proposals addressing network adequacy in the proposed rule.

Related Resources

Letter/Comment
Public
AHA expresses support of the Health Care Broadband Expansion During COVID-19 Act, which proposes improvements to the Federal Communications…
Letter/Comment
Public
AHA Expresses Support for the Health Care Broadband Expansion During COVID-19 Act, which proposes improvements to the Federal Communications Commission (FCC)…
Special Bulletin
Member
The Centers for Medicare & Medicaid Services (CMS) May 22 released its final rule implementing policy changes for the Medicare Advantage (MA) and Part D…
Letter/Comment
Public
Dear Chairman Pai: I am writing to update the record on and urge expedited approval of the American Hospital Association’s pending Petition for Partial…
Webinar Recordings
Member
A panel of 4 experts discussed federal policy emerging from Congress and the Administration under COVID-19 focusing on rural health priorities and took…
Special Bulletin
Public
The Centers for Medicare & Medicaid Services (CMS) yesterday released a number of new waivers related to COVID-19. The waivers apply nationwide and are…